Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 12 studies | 37% ± 12% | |
glutamatergic neuron | 11 studies | 44% ± 27% | |
oligodendrocyte precursor cell | 8 studies | 32% ± 12% | |
interneuron | 6 studies | 46% ± 23% | |
macrophage | 6 studies | 23% ± 6% | |
GABAergic neuron | 6 studies | 61% ± 21% | |
epithelial cell | 5 studies | 22% ± 2% | |
type I pneumocyte | 5 studies | 30% ± 8% | |
endothelial cell of lymphatic vessel | 4 studies | 20% ± 4% | |
neuron | 3 studies | 34% ± 14% | |
endothelial cell | 3 studies | 43% ± 14% | |
GABAergic interneuron | 3 studies | 36% ± 11% | |
granule cell | 3 studies | 21% ± 2% | |
retinal ganglion cell | 3 studies | 35% ± 3% | |
OFF-bipolar cell | 3 studies | 49% ± 20% | |
retina horizontal cell | 3 studies | 24% ± 7% | |
club cell | 3 studies | 24% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 13 studies | 36% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 1960.39 | 240 / 245 | 100% | 47.56 | 501 / 502 |
pancreas | 100% | 2316.02 | 328 / 328 | 94% | 10.42 | 168 / 178 |
stomach | 99% | 1682.81 | 356 / 359 | 89% | 9.43 | 255 / 286 |
kidney | 99% | 2258.52 | 88 / 89 | 84% | 14.57 | 753 / 901 |
breast | 90% | 779.19 | 413 / 459 | 91% | 26.32 | 1022 / 1118 |
brain | 99% | 4024.66 | 2612 / 2642 | 79% | 13.53 | 560 / 705 |
intestine | 84% | 769.02 | 807 / 966 | 89% | 8.73 | 469 / 527 |
adrenal gland | 100% | 4473.39 | 258 / 258 | 72% | 11.62 | 165 / 230 |
lung | 98% | 1373.52 | 564 / 578 | 66% | 4.80 | 759 / 1155 |
liver | 98% | 1104.47 | 221 / 226 | 56% | 2.92 | 226 / 406 |
uterus | 91% | 1147.51 | 155 / 170 | 53% | 3.90 | 242 / 459 |
ovary | 94% | 1242.02 | 169 / 180 | 43% | 2.39 | 184 / 430 |
bladder | 57% | 432.29 | 12 / 21 | 65% | 4.88 | 328 / 504 |
esophagus | 63% | 1007.00 | 915 / 1445 | 54% | 5.76 | 99 / 183 |
thymus | 60% | 345.72 | 394 / 653 | 52% | 2.95 | 314 / 605 |
peripheral blood | 79% | 2616.12 | 736 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 71% | 485.72 | 942 / 1335 | 0% | 0 | 0 / 0 |
spleen | 68% | 472.30 | 163 / 241 | 0% | 0 | 0 / 0 |
skin | 34% | 205.66 | 622 / 1809 | 29% | 1.40 | 136 / 472 |
adipose | 61% | 388.71 | 739 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 51% | 2.82 | 23 / 45 |
heart | 44% | 316.69 | 381 / 861 | 0% | 0 | 0 / 0 |
muscle | 16% | 140.32 | 125 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 5% | 0.21 | 4 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007173 | Biological process | epidermal growth factor receptor signaling pathway |
GO_0016197 | Biological process | endosomal transport |
GO_0006897 | Biological process | endocytosis |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | REPS2 |
Protein name | RalBP1-associated Eps domain-containing protein 2 (Partner of RalBP1) (RalBP1-interacting protein 2) |
Synonyms | POB1 |
Description | FUNCTION: Involved in ligand-dependent receptor mediated endocytosis of the EGF and insulin receptors as part of the Ral signaling pathway . By controlling growth factor receptors endocytosis may regulate cell survival . Through ASAP1 may regulate cell adhesion and migration . . |
Accessions | ENST00000303843.7 [Q8NFH8-4] Q8NFH8 ENST00000357277.8 [Q8NFH8-1] |